Key facts
- It has raised $2.0M; the latest was Early Stage VC ($1.5M) in May 2025.
- Notable investors include Y Combinator, Unpopular Ventures, E14 Fund.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for G LNK
- ·The full record, as it builds
Funding rounds
No funding rounds for G LNK are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About G LNK
Developer of an AI-powered platform intended to facilitate collaboration in healthcare. The company offers a precision search engine, natural language queries, analyzes credentials, assesses compatibility, and automates tiering to prioritize key collaborators, identify and unlock tailored grants, events, and publications aligned with the team's strategic goals, enabling healthcare professionals to reduce growth medical costs and allocate more resources towards changing lives.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 6
- Website
- glnkco.com/
- Ownership
- Privately Held (backing)
G LNK doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in G LNK shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on G LNK in its N-PORT filings yet. We sweep new filings monthly.